A detailed history of Hanson & Doremus Investment Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 75 shares of BSX stock, worth $7,703. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Holding current value
$7,703
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$83.62 - $91.5 $6,271 - $6,862
75 New
75 $6,000
Q2 2023

Jul 18, 2023

BUY
$49.72 - $54.64 $15,860 - $17,430
319 New
319 $17,000
Q1 2022

Apr 22, 2022

SELL
$40.9 - $45.1 $2,822 - $3,111
-69 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$41.23 - $45.88 $2,844 - $3,165
69 New
69 $2,000
Q2 2021

Jul 22, 2021

SELL
$38.58 - $44.24 $2,662 - $3,052
-69 Closed
0 $0
Q1 2021

May 03, 2021

BUY
$35.27 - $39.67 $2,433 - $2,737
69 New
69 $3,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Hanson & Doremus Investment Management Portfolio

Follow Hanson & Doremus Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.